Systematic Financial Management’s Lifecore Biomedical LFCR Stock Holding History

Systematic Financial Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-51,788	Closed	-$604K	–	639
2015 Q3	$604K	Sell	51,788 -165,722	-76%	-$2.2M	0.01%	590
2015 Q2	$3.14M	Buy	+217,510	New	+$3.14M	0.03%	354
2014 Q1	–	Sell	-260,650	Closed	-$3.16M	–	707
2013 Q4	$3.16M	Sell	260,650 -2,875	-1%	-$34.3K	0.02%	363
2013 Q3	$3.21M	Sell	263,525 -2,025	-0.8%	-$28.3K	0.03%	357
2013 Q2	$3.51M	Buy	+265,550	New	+$3.67M	0.03%	338

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Systematic Financial Management's LFCR Position: Q4 2015 in Review

Systematic Financial Management sold out of Lifecore Biomedical (LFCR) in Q4 2015, closing a stake of 51,788 shares — an estimated $604K sold.

Systematic Financial Management first reported a position in LFCR in Q2 2013 and held it in 5 quarters. The position peaked at $3.51M in Q2 2013. 109 funds tracked by Wall St. Rank hold LFCR as of Q4 2015.

Systematic Financial Management reported no remaining Lifecore Biomedical position as of Q4 2015 after selling out during the quarter.
Systematic Financial Management sold 51,788 Lifecore Biomedical shares in Q4 2015, an estimated $604K.
Systematic Financial Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 5 quarters.
Systematic Financial Management's Lifecore Biomedical position peaked at $3.51M in Q2 2013.
109 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2015.

Based on Systematic Financial Management's 13F filing for Q4 2015, filed 10 Feb 2016.